File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Improved Survival with Screening for Hepatocellular Carcinoma in Chronic Hepatitis B and Liver Cirrhosis

TitleImproved Survival with Screening for Hepatocellular Carcinoma in Chronic Hepatitis B and Liver Cirrhosis
Authors
Issue Date2005
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
Citation
The 56th Annual Meeting and Postgraduate Course of the American Association of Liver Diseases (AASLD 2005), San Francisco, CA., 11-15 November 2005. In Hepatology, 2005, v. 42 suppl. 1, p. 394A, abstract no. 501 How to Cite?
AbstractBACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide with the major risk factor being liver cirrhosis. Survival for patients who presents with symptomatic HCC is poor. We report our experience with HCC screening in chronic hepatitis B and liver cirrhosis in conjunction with our National Hepatitis B Screening programme, and to determine whether screening in these patients improve survival. METHODS: All patients referred for management of HCC have been followed by New Zealand Liver Transplant Unit, including all cases detected through the national hepatitis B screening programme (since 1999) …
Persistent Identifierhttp://hdl.handle.net/10722/102024
ISSN
2015 Impact Factor: 11.711
2015 SCImago Journal Rankings: 4.752

 

DC FieldValueLanguage
dc.contributor.authorFung, JYYen_HK
dc.contributor.authorGane, Een_HK
dc.contributor.authorMcCall, Jen_HK
dc.contributor.authorHolden, Aen_HK
dc.date.accessioned2010-09-25T20:14:01Z-
dc.date.available2010-09-25T20:14:01Z-
dc.date.issued2005en_HK
dc.identifier.citationThe 56th Annual Meeting and Postgraduate Course of the American Association of Liver Diseases (AASLD 2005), San Francisco, CA., 11-15 November 2005. In Hepatology, 2005, v. 42 suppl. 1, p. 394A, abstract no. 501en_HK
dc.identifier.issn0270-9139en_HK
dc.identifier.urihttp://hdl.handle.net/10722/102024-
dc.description.abstractBACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide with the major risk factor being liver cirrhosis. Survival for patients who presents with symptomatic HCC is poor. We report our experience with HCC screening in chronic hepatitis B and liver cirrhosis in conjunction with our National Hepatitis B Screening programme, and to determine whether screening in these patients improve survival. METHODS: All patients referred for management of HCC have been followed by New Zealand Liver Transplant Unit, including all cases detected through the national hepatitis B screening programme (since 1999) …-
dc.languageengen_HK
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/en_HK
dc.relation.ispartofHepatologyen_HK
dc.rightsHepatology. Copyright © John Wiley & Sons, Inc.en_HK
dc.titleImproved Survival with Screening for Hepatocellular Carcinoma in Chronic Hepatitis B and Liver Cirrhosisen_HK
dc.typeConference_Paperen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0270-9139&volume=42 &issue=4 S1&spage=394A&epage=&date=2005&atitle=Improved+Survival+with+Screening+for+Hepatocellular+Carcinoma+in+Chronic+Hepatitis+B+and+Liver+Cirrhosisen_HK
dc.identifier.emailFung, JYY: jfung@sicklehut.comen_HK
dc.identifier.authorityFung, JYY=rp00518en_HK
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1002/hep.20924-
dc.identifier.hkuros132172en_HK
dc.identifier.volume42en_HK
dc.identifier.issuesuppl. 1en_HK
dc.identifier.spage394A, abstract no. 501en_HK
dc.identifier.epage394A, abstract no. 501-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats